PURPOSE: To describe the ocular findings of 12 subjects with paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance (MGUS). METHODS: Ocular examination included corneal spectral domain optical coherence tomography. In three individuals with an initial diagnosis of a lattice or Thiel-Behnke corneal dystrophy, the TGFBI gene was screened by conventional Sanger sequencing. RESULTS: We confirmed a diagnosis of MGUS by systemic examination and serum protein electrophoresis in 12 individuals (9 males and 3 females), with a mean age at presentation of 52.2 years (range 24-63 years) and mean follow-up 6.4 years (range 0-17 years). The best-corrected visual acuity (BCVA) at presentation ranged from 1.25 to 0.32. In all individuals, the corneal opacities were bilateral. The appearances were diverse and included superficial reticular opacities and nummular lesions, diffuse posterior stromal opacity, stromal lattice lines, superficial and stromal crystalline deposits, superficial haze and a superficial ring of hypertrophic tissue. In one individual, with opacities first recorded at 24 years of age, we documented the progression of corneal disease over the subsequent 17 years. In another individual, despite systemic treatment for MGUS, recurrence of deposits was noted following bilateral penetrating keratoplasties. The three individuals initially diagnosed with inherited corneal dystrophy were negative for TGFBI mutations by direct sequencing. CONCLUSION: A diagnosis of MGUS should be considered in patients with bilateral corneal opacities. The appearance can mimic corneal dystrophies or cystinosis. In our experience, systemic treatment of MGUS did not prevent recurrence of paraproteinemic keratopathy following keratoplasty.

BIOCEV 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Ophthalmology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Moorfields Eye Hospital London UK

Research Unit for Rare Diseases Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

UCL Institute of Ophthalmology London UK

Zobrazit více v PubMed

Bourne WM, Kyle RA, Brubaker RF & Greipp PR (1989): Incidence of corneal crystals in the monoclonal gammopathies. Am J Ophthalmol 107: 192-193.

Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N & Merlini G (2018): Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 132: 1478-1485.

Garibaldi DC, Gottsch J, de la Cruz Z, Haas M & Green WR (2005): Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias. Surv Ophthalmol 50: 61-80.

Glavey SV & Leung N (2016): Monoclonal gammopathy: The good, the bad and the ugly. Blood Rev 30: 223-231.

Hawkins AS, Stein RM, Gaines BI & Deutsch TA (2001): Ocular deposition of copper associated with multiple myeloma. Am J Ophthalmol 131: 257-259.

Kamal KM, Rayner SA, Chen MC & Aldave AJ (2009): Classic lattice corneal dystrophy associated with monoclonal gammopathy after exclusion of a TGFBI mutation. Cornea 28: 97-98.

Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd (2002): A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346: 564-569.

Kyle RA, Therneau TM, Rajkumar SV et al. (2006): Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354: 1362-1369.

Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR & Rajkumar SV (2018): Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med 378: 241-249.

Lewis RA, Hultquist DE, Baker BL, Falls HF, Gershowitz H & Penner JA (1976): Hypercupremia associated with a monoclonal immunoglobulin. J Lab Clin Med 88: 375-388.

Lisch W, Saikia P, Pitz S, Pleyer U, Lisch C, Jaeger M & Rohrbach JM (2012): Chameleon-like appearance of immunotactoid keratopathy. Cornea 31: 55-58.

Lisch W, Wasielica-Poslednik J, Kivela T et al. (2016): The hematologic definition of monoclonal gammopathy of undetermined significance in relation to paraproteinemic keratopathy (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc 114: T7.

Liskova P, Klintworth GK, Bowling BL et al. (2008): Phenotype associated with the H626P mutation and other changes in the TGFBI gene in Czech families. Ophthalmic Res 40: 105-108.

Lopez de la Fuente C, Sanchez-Cano A, Segura F, Hospital EO & Pinilla I (2016): Evaluation of total corneal thickness and corneal layers with spectral-domain optical coherence tomography. J Refract Surg 32: 27-32.

Milman T, Kao AA, Chu D et al. (2015): Paraproteinemic keratopathy: the expanding diversity of clinical and pathologic manifestations. Ophthalmology 122: 1748-1756.

Genotype-Phenotype Correlations in Corneal Dystrophies: Advances in Molecular Genetics and Therapeutic Insights